124 related articles for article (PubMed ID: 22180297)
1. Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis.
Abdulwahab A; Sykes J; Kamel-Reid S; Chang H; Brandwein JM
Cancer; 2012 Aug; 118(16):3962-7. PubMed ID: 22180297
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to
Aldoss I; Stiller T; Tsai NC; Song JY; Cao T; Bandara NA; Salhotra A; Khaled S; Aribi A; Al Malki MM; Mei M; Ali H; Spielberger R; O'Donnell M; Snyder D; Slavin T; Nakamura R; Stein AS; Forman SJ; Marcucci G; Pullarkat V
Haematologica; 2018 Oct; 103(10):1662-1668. PubMed ID: 29903756
[TBL] [Abstract][Full Text] [Related]
3. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
[TBL] [Abstract][Full Text] [Related]
4. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
5. Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Brunet S; Bergua J; Tormo M; García-Boyero R; Sarrà J; Del Potro E; Grande C; Barba P; Bernal T; Amigo ML; Grau J; Cervera J; Feliu E;
Leuk Lymphoma; 2017 Jan; 58(1):145-152. PubMed ID: 27122129
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and molecular biologic characteristics of 36 cases of leukemia with 11q23/mll].
Zhao J; Yin YM; Zhao YL; Sun Y; Wang JB; Zhong J; Zhang X; Fei XH; Shan FX; Liu HX; Wang T; Wang H; Tong CR; Wu T; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1381-5. PubMed ID: 21176334
[TBL] [Abstract][Full Text] [Related]
7. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.
Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J
Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation.
Kato M; Hasegawa D; Koh K; Kato K; Takita J; Inagaki J; Yabe H; Goto H; Adachi S; Hayakawa A; Takeshita Y; Sawada A; Atsuta Y; Kato K
Br J Haematol; 2015 Feb; 168(4):564-70. PubMed ID: 25302748
[TBL] [Abstract][Full Text] [Related]
10. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.
Pui CH; Behm FG; Downing JR; Hancock ML; Shurtleff SA; Ribeiro RC; Head DR; Mahmoud HH; Sandlund JT; Furman WL
J Clin Oncol; 1994 May; 12(5):909-15. PubMed ID: 8164041
[TBL] [Abstract][Full Text] [Related]
11. Mutational patterns in therapy-related acute lymphoblastic leukemia subgroups: one step closer to unveiling the genetic odyssey.
Hofer KD; Bühler MM; Roncador M; Rechsteiner M; Maggio EM; Tchinda J; Schanz U; Haralambieva E; Widmer CC
Leuk Lymphoma; 2024 Jun; 65(6):808-815. PubMed ID: 38385617
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related B-lymphoblastic leukemia associated with Philadelphia chromosome and MLL rearrangement: Single institution experience and the review of the literature.
Matnani R; Parekh V; Borate U; Brazelton J; Reddy V; Peker D
Pathol Int; 2015 Oct; 65(10):536-40. PubMed ID: 26259760
[TBL] [Abstract][Full Text] [Related]
13. MLL partner genes in secondary acute lymphoblastic leukemia: report of a new partner PRRC1 and review of the literature.
Douet-Guilbert N; Eveillard JR; Meyer C; Ugo V; Le Bris MJ; Basinko A; Morel F; Marschalek R; De Braekeleer M
Leuk Res; 2014 Nov; 38(11):1316-9. PubMed ID: 25205603
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia.
Chillón MC; Gómez-Casares MT; López-Jorge CE; Rodriguez-Medina C; Molines A; Sarasquete ME; Alcoceba M; Miguel JD; Bueno C; Montes R; Ramos F; Rodríguez JN; Giraldo P; Ramírez M; García-Delgado R; Fuster JL; González-Díaz M; Menendez P
Leukemia; 2012 Nov; 26(11):2360-6. PubMed ID: 22705992
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates.
Boer JM; Koenders JE; van der Holt B; Exalto C; Sanders MA; Cornelissen JJ; Valk PJ; den Boer ML; Rijneveld AW
Haematologica; 2015 Jul; 100(7):e261-4. PubMed ID: 25769542
[No Abstract] [Full Text] [Related]
16. Early onset of acute lymphoblastic leukemia with MLL rearrangement after autologous stem cell transplantation for multiple myeloma.
Ueda K; Yamamoto G; Shinohara A; Hangaishi A; Kurokawa M
Ann Hematol; 2009 Aug; 88(8):813-4. PubMed ID: 19127363
[No Abstract] [Full Text] [Related]
17. [Therapy-related acute leukemia: study of 23 pacients].
Motlló C; Sancho JM; García O; Granada I; Millá F; Ribera JM
Med Clin (Barc); 2011 Oct; 137(10):449-52. PubMed ID: 21696789
[TBL] [Abstract][Full Text] [Related]
18. Nationwide survey of therapy-related leukemia in childhood in Japan.
Imamura T; Taga T; Takagi M; Kawasaki H; Koh K; Taki T; Adachi S; Manabe A; Ishida Y; ;
Int J Hematol; 2018 Jul; 108(1):91-97. PubMed ID: 29574603
[TBL] [Abstract][Full Text] [Related]
19. Five most common prognostically important fusion oncogenes are detected in the majority of Pakistani pediatric acute lymphoblastic leukemia patients and are strongly associated with disease biology and treatment outcome.
Awan T; Iqbal Z; Aleem A; Sabir N; Absar M; Rasool M; Tahir AH; Basit S; Khalid AM; Sabar MF; Asad S; Ali AS; Mahmood A; Akram M; Saeed T; Saleem A; Mohsin D; Shah IH; Khalid M; Asif M; Haq R; Iqbal M; Akhtar T
Asian Pac J Cancer Prev; 2012; 13(11):5469-75. PubMed ID: 23317202
[TBL] [Abstract][Full Text] [Related]
20. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]